{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:06:15Z","timestamp":1787612775455,"version":"build-2736575974"},"reference-count":47,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2018,9,25]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Preclinical Alzheimer\u2019s disease (AD) is defined by cerebral amyloid-\u03b2 positivity (A\u03b2+) in cognitively normal (CN) older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To estimate the risk of progression to the symptomatic stages of AD due to PET A\u03b2+ and the extent that progression was influenced by other demographic, genetic, and clinical characteristics in a\u00a0large prospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Fine-Gray subdistribution modeling was used to examine the risk of progression from CN to MCI\/dementia due to A\u03b2+, APOE \u025b4 carriage, and their interaction in the Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging CN cohort ( n\u200a=\u200a599) over 8 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>17.7% A\u03b2+ and 8.1% A\u03b2\u2013progressed over 8 years (OR: 2.43). Risk of progression for A\u03b2+ was 65\u2013104% greater than A\u03b2\u2013. A\u03b2+ APOE \u025b4 carriers were at 348% greater risk than all other participants. Significant risk factors of progression in A\u03b2+ were age (HR: 1.05), PET SUVR (HR: 2.49) and APOE \u025b4 carriage (HR: 2.63); only age was a\u00a0significant risk factor in A\u03b2\u2013(HR: 1.09). A\u03b2\u2013progressors were not near the threshold for A\u03b2+. These relationships were not moderated by hypertension, diabetes, obesity, or stroke\/TIA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A\u03b2+ is an important prognostic marker for progression from CN to MCI\/dementia in older adults and APOE \u025b4 carriage provides further predictive value in the presence of A\u03b2+. These data suggest that A\u03b2-associated clinical progression is consistent with clinical-pathological models of AD, whereas progression in the absence of elevated A\u03b2 deposition may be the result of neuropathological processes other than AD that accumulate with age.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/jad-180507","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T13:55:42Z","timestamp":1535118942000},"page":"1313-1325","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":27,"title":["Relationship Between Amyloid-\u03b2 Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults"],"prefix":"10.1177","volume":"65","author":[{"given":"Christa","family":"Dang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia"},{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karra D.","family":"Harrington","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"},{"name":"Cooperative Research Centre for Mental Health, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Ying","family":"Lim","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ames","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Academic Unit for Psychiatry of Old Age, The University of Melbourne, Parkville, VIC, Australia"},{"name":"National Ageing Research Institute, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hassenstab","sequence":"additional","affiliation":[{"name":"Charles F. and Joanne Knight Alzheimer\u2019s Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA"},{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"},{"name":"Department of Psychological and Brain Sciences, Washington University, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Laws","sequence":"additional","affiliation":[{"name":"Cooperative Research Centre for Mental Health, Parkville, VIC, Australia"},{"name":"Collaborative Genomics Group, Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia"},{"name":"School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaf","family":"Yassi","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"},{"name":"Department of Medicine and Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Hickey","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Rainey-Smith","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia"},{"name":"Australian Alzheimer\u2019s Disease Research Unit, Hollywood Private Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Robertson","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid R.","family":"Sohrabi","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia"},{"name":"School of Psychiatry and Clinical Neurosciences, University of WA, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Salvado","sequence":"additional","affiliation":[{"name":"CSIRO Health and Biosecurity, the Australian eHealth Research Centre, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weinborn","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia"},{"name":"Australian Alzheimer\u2019s Disease Research Unit, Hollywood Private Hospital, Perth, Western Australia, Australia"},{"name":"School of Psychological Science, University of Western Australia, Crawley, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"},{"name":"Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia"},{"name":"Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia"},{"name":"Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maruff","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia"},{"name":"CogState Ltd., Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the AIBL Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70291-0"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4668"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2016.09.002"},{"key":"ref006","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.272"},{"key":"ref007","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318246d67a"},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70044-9"},{"key":"ref009","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2013.02.006"},{"key":"ref010","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0629"},{"key":"ref011","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007941"},{"key":"ref012","unstructured":"U.S. Food and Drug Administration (2018) Early Alzheimer\u2019s Disease: Developing Drugs for Treatment \u2013 Guidance for Industry, https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM596728.pdf"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.03.014"},{"key":"ref014","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30125-9"},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.6669"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00472-3"},{"key":"ref017","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70194-7"},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.12.008"},{"key":"ref019","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70325-2"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170072"},{"key":"ref021","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000431"},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139082"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25071"},{"key":"ref024","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu393"},{"key":"ref025","doi-asserted-by":"publisher","DOI":"10.1159\/000115751"},{"key":"ref026","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610209009405"},{"key":"ref027","unstructured":"National Health and Medical Research Council (2001) Australian Alcohol Guidelines, Health Risks and Benefits. https:\/\/www.nhmrc.gov.au\/guidelines-publications\/ds9."},{"key":"ref028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01380.x"},{"key":"ref029","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"ref030","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20513-y"},{"key":"ref031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"ref032","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610292000991"},{"key":"ref033","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.04.007"},{"key":"ref034","doi-asserted-by":"publisher","DOI":"10.9734\/AIR\/2014\/11599"},{"key":"ref035","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20170052"},{"key":"ref036","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3471"},{"key":"ref037","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.3098"},{"key":"ref038","first-page":"1","volume":"3052","author":"Lim YY","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref039","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002156"},{"key":"ref040","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70284-2"},{"key":"ref041","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24454"},{"key":"ref042","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2006.07.001"},{"key":"ref043","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww159"},{"key":"ref044","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acw106"},{"key":"ref045","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150128"},{"key":"ref046","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-2-26"},{"key":"ref047","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31363-6"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-180507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JAD-180507","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-180507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:01Z","timestamp":1777370881000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-180507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,9,25]]}},"alternative-id":["10.3233\/JAD-180507"],"URL":"https:\/\/doi.org\/10.3233\/jad-180507","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]}}}